検索結果 1 - 5 結果 / 5 検索語 'Seyed Reza Mousavi (13223324)', 処理時間: 0.01秒 結果の絞り込み
  1. 1
    The non-inferiority margin in Phase III clinical trial of SnaFab compared to Razi antivenom in snakebites.

    The non-inferiority margin in Phase III clinical trial of SnaFab compared to Razi antivenom in snakebites. 著者: Seyed Reza Mousavi (13223324)

    出版事項 2025
    お気に入りに追加
    保存先:
  2. 2
    Snakebite severity classification in clinical trial of SnaFab vs. Razi antivenom in snakebite victims [14,57,58].

    Snakebite severity classification in clinical trial of SnaFab vs. Razi antivenom in snakebite victims [14,57,58]. 著者: Seyed Reza Mousavi (13223324)

    出版事項 2025
    お気に入りに追加
    保存先:
  3. 3
    Adverse events during follow-up period in Phase III non-inferiority clinical trial of SnaFab compared to Razi antivenom in snakebites.

    Adverse events during follow-up period in Phase III non-inferiority clinical trial of SnaFab compared to Razi antivenom in snakebites. 著者: Seyed Reza Mousavi (13223324)

    出版事項 2025
    お気に入りに追加
    保存先:
  4. 4
    Consort Chart of Phase III clinical trial of SnaFab compare to Razi antivenom in snakebites.

    Consort Chart of Phase III clinical trial of SnaFab compare to Razi antivenom in snakebites. 著者: Seyed Reza Mousavi (13223324)

    出版事項 2025
    お気に入りに追加
    保存先:
  5. 5
    Demographic information and clinical presentation of victims in Phase III non-inferiority clinical trial of SnaFab compare to Razi antivenom in snakebites.

    Demographic information and clinical presentation of victims in Phase III non-inferiority clinical trial of SnaFab compare to Razi antivenom in snakebites. 著者: Seyed Reza Mousavi (13223324)

    出版事項 2025
    お気に入りに追加
    保存先:

検索ツール: